news & Services

PRESS RELEASEs

Vienna, May 18th 2021

P+F Products + Features GmbH gains CE Mark approval for TricValve® Transcatheter Bicaval Valves System

VIENNA, December 22nd, 2020

TricValve® Transcatheter Bicaval Valves System granted Designation as Breakthrough Device by the U.S. Food and Drug Administration (FDA)

Publications

Downloads

TRICVALVE®

TRICVALVE®
Training Material

The only complete solution for treatment of tricuspid regurgitation using cavi. 

TRICVALVE®
CT Protocol

Cavi - Visualization of vena cava inferior and superior

TRICVALVE®
Screening Protocol

Inclusion and Exclusion Criteria

VIENNA AORTIC

Vienna Aortic Valve SE

Self-expandable Transcatheter Valve

Media Library

TRICVALVE®

TricValve® - Transcatheter Bicaval Valves System is a system of two self-expanding biological valves for the treatment of patients with hemodynamically relevant tricuspid insufficiency and caval reflux.

TRICUSPID REGURGITATION

In this short summary, Hon. Prof. Dr. Katharina Kiss talks about what you need to know about tricuspid regurgitation and current therapy

Follow Us

© P+F Products + Features GmbH

This site is intended for healthcare professionals.
Are you a healthcare professional?